• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪组织分泌的细胞因子介导三阴性乳腺癌中的肿瘤增殖和转移。

Cytokines secreted from adipose tissues mediate tumor proliferation and metastasis in triple negative breast cancer.

机构信息

Head and Neck Breast Surgery, The Yuebei People's Hospital of Shaoguan, Guangdong Province, 512025, Shaoguan, China.

Department of Anesthesiology, Maternal and Child Health Hospital of Hubei Province, Hubei Province, 430070, Wuhan, China.

出版信息

BMC Cancer. 2022 Aug 13;22(1):886. doi: 10.1186/s12885-022-09959-6.

DOI:10.1186/s12885-022-09959-6
PMID:35964108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9375239/
Abstract

BACKGROUND

Obesity is a high-risk factor for development and poor prognosis of triple-negative breast cancer (TNBC), which was considered as a high malignant and poor clinical outcome breast cancer subtype. TNBC proliferation and migration regulated by obesity is complex. Here, we studied effects of cytokines secreted from adipose tissue on development of TNBC.

METHODS

Forty postmenopausal cases by Yuebei People's Hospital of Shaoguan with stage I/IIA TNBC were enrolled. Cytokine concentrations were examined using ELISA analysis. Proliferation and migration of TNBC cell lines were performed using CCK8 assays and Transwell tests. The Log-rank (Mantel-Cox) test, two-tailed Mann-Whitney U test and two-tailed unpaired t test were performed using GraphPad Prism 8.4.2.

RESULTS

Survival analysis indicated that obese patients with TNBC had worse disease free survival (DFS) as compared with normal weight group (Hazard Ratio 4.393, 95% confidence interval (CI) of ratio 1.071-18.02, p < 0.05). Obese patients with TNBC had severe insulin resistance and high plasma triglycerides. However, plasma adiponectin concentration was decreased and interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) concentration was increased in obese TNBC patients as compared with the nonobese group. The similar results were found in the cytokine secretion from adipose tissues and insulin-resistant adipocytes. The secretion of adipose tissue from obese TNBC patients could promote proliferation and migration of TNBC cell lines, including MDA-MB-157, MDA-MB-231, MDA-MB-453 and HCC38 cells. These TNBC cell lines co-incubated with insulin-resistant 3T3-L1 adipocytes or supplementing these cytokines medium also exhibited increase of proliferative and migratory capacity.

CONCLUSION

TNBC patients with obesity had worse prognosis compared with the normal weight groups. Alteration of cytokines secreted from adipose tissues mediated proliferation and migration of TNBC, leading to tumor progression in TNBC patients with obesity.

摘要

背景

肥胖是三阴性乳腺癌(TNBC)发生和预后不良的高危因素,TNBC 被认为是一种恶性程度高、临床结局差的乳腺癌亚型。肥胖调节的 TNBC 增殖和迁移是复杂的。在这里,我们研究了脂肪组织分泌的细胞因子对 TNBC 发展的影响。

方法

纳入韶关粤北人民医院 40 例绝经后Ⅰ/ⅡA 期 TNBC 患者,采用 ELISA 分析检测细胞因子浓度。采用 CCK8 检测和 Transwell 检测 TNBC 细胞系的增殖和迁移。使用 GraphPad Prism 8.4.2 进行 Log-rank(Mantel-Cox)检验、双侧 Mann-Whitney U 检验和双侧非配对 t 检验。

结果

生存分析表明,与正常体重组相比,肥胖 TNBC 患者无病生存期(DFS)更差(风险比 4.393,比值 95%置信区间(CI)为 1.071-18.02,p<0.05)。肥胖 TNBC 患者存在严重的胰岛素抵抗和高血浆甘油三酯,而肥胖 TNBC 患者的血浆脂联素浓度降低,白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)浓度升高与非肥胖组相比。在肥胖 TNBC 患者的脂肪组织和胰岛素抵抗脂肪细胞中也发现了类似的结果。肥胖 TNBC 患者的脂肪组织分泌可促进 TNBC 细胞系,包括 MDA-MB-157、MDA-MB-231、MDA-MB-453 和 HCC38 细胞的增殖和迁移。这些 TNBC 细胞系与胰岛素抵抗的 3T3-L1 脂肪细胞共孵育或补充这些细胞因子培养基也表现出增殖和迁移能力的增加。

结论

与正常体重组相比,肥胖的 TNBC 患者预后更差。脂肪组织分泌的细胞因子改变介导 TNBC 的增殖和迁移,导致肥胖 TNBC 患者的肿瘤进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/ed6572f1f269/12885_2022_9959_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/27c601bd055b/12885_2022_9959_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/b4617d589653/12885_2022_9959_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/c03504b06693/12885_2022_9959_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/2fc4bbcee350/12885_2022_9959_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/ed6572f1f269/12885_2022_9959_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/27c601bd055b/12885_2022_9959_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/b4617d589653/12885_2022_9959_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/c03504b06693/12885_2022_9959_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/2fc4bbcee350/12885_2022_9959_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d90/9375239/ed6572f1f269/12885_2022_9959_Fig5_HTML.jpg

相似文献

1
Cytokines secreted from adipose tissues mediate tumor proliferation and metastasis in triple negative breast cancer.脂肪组织分泌的细胞因子介导三阴性乳腺癌中的肿瘤增殖和转移。
BMC Cancer. 2022 Aug 13;22(1):886. doi: 10.1186/s12885-022-09959-6.
2
Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis.肥胖相关的代谢炎症通过白细胞介素 6/STAT3/五聚素 3/基质金属蛋白酶 7 轴促进三阴性乳腺癌的进展。
Int Immunopharmacol. 2024 Jul 30;136:112332. doi: 10.1016/j.intimp.2024.112332. Epub 2024 May 27.
3
Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.蒲公英提取物通过抑制 IL-10/STAT3/PD-L1 信号通路抑制肿瘤相关巨噬细胞微环境中三阴性乳腺癌细胞的恶性表型。
J Ethnopharmacol. 2021 Jun 28;274:113978. doi: 10.1016/j.jep.2021.113978. Epub 2021 Mar 11.
4
Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.毛蕊异黄酮通过下调新型雌激素受体-α剪接变体 ER-α30 介导的 PI3K/AKT 信号通路抑制三阴性乳腺癌的进展。
Phytomedicine. 2023 Sep;118:154924. doi: 10.1016/j.phymed.2023.154924. Epub 2023 Jun 14.
5
Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.Notch 介导的肿瘤-基质-炎症网络促进三阴性乳腺癌的侵袭特性和 CXCL8 的表达。
Front Immunol. 2019 Apr 24;10:804. doi: 10.3389/fimmu.2019.00804. eCollection 2019.
6
miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.miR-17-5p 通过靶向 ETV1 抑制三阴性乳腺癌细胞增殖和侵袭。
BMC Cancer. 2017 Nov 10;17(1):745. doi: 10.1186/s12885-017-3674-x.
7
Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.敲低激酶家族 15 抑制体外癌细胞增殖及其在三阴性乳腺癌中的临床相关性。
Curr Mol Med. 2019;19(2):147-155. doi: 10.2174/1566524019666190308122108.
8
USP2 promotes cell migration and invasion in triple negative breast cancer cell lines.USP2促进三阴性乳腺癌细胞系中的细胞迁移和侵袭。
Tumour Biol. 2015 Jul;36(7):5415-23. doi: 10.1007/s13277-015-3207-7. Epub 2015 Feb 17.
9
Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models.肥胖改变的脂肪干细胞产生的瘦素促进三阴性乳腺癌在原位异种移植和患者来源异种移植模型中的转移,但不促进肿瘤发生。
Breast Cancer Res. 2019 May 22;21(1):67. doi: 10.1186/s13058-019-1153-9.
10
[The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].[泛素连接酶Cullin3对三阴性乳腺癌细胞增殖、迁移和侵袭的影响及其机制探讨]
Zhonghua Yi Xue Za Zhi. 2024 May 28;104(20):1868-1878. doi: 10.3760/cma.j.cn12137-20240110-00071.

引用本文的文献

1
Dynamic phenotypes of preclinical and clinical obesity in relation to new-onset cancer risk: A longitudinal analysis from the UK biobank.临床前和临床肥胖的动态表型与新发癌症风险的关系:来自英国生物银行的纵向分析。
Diabetes Obes Metab. 2025 Sep;27(9):5291-5301. doi: 10.1111/dom.16582. Epub 2025 Jul 2.
2
Body composition as a potential biomarker of recurrence risk in patients with triple-negative breast cancer.身体成分作为三阴性乳腺癌患者复发风险的潜在生物标志物。
Breast Cancer Res Treat. 2025 Jun;211(3):627-635. doi: 10.1007/s10549-025-07675-w. Epub 2025 Mar 11.
3
A Mendelian randomization study on associations between plasma lipidome, circulating inflammatory proteins, and erectile dysfunction.

本文引用的文献

1
Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis.肥胖与乳腺癌结局的相关性:基于癌症亚型的荟萃分析。
J Natl Cancer Inst. 2021 Nov 2;113(11):1465-1475. doi: 10.1093/jnci/djab023.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Rosiglitazone ameliorates skeletal muscle insulin resistance by decreasing free fatty acids release from adipocytes.
一项关于血浆脂质组、循环炎症蛋白与勃起功能障碍之间关联的孟德尔随机化研究。
Transl Androl Urol. 2024 Dec 31;13(12):2724-2734. doi: 10.21037/tau-24-378. Epub 2024 Dec 28.
4
Body composition as a novel biomarker of recurrence risk in patients with triple-negative breast cancer.身体成分作为三阴性乳腺癌患者复发风险的一种新型生物标志物。
Res Sq. 2024 Dec 17:rs.3.rs-5437121. doi: 10.21203/rs.3.rs-5437121/v1.
5
Influence of Type 2 Diabetes and Adipose Tissue Dysfunction on Breast Cancer and Potential Benefits from Nutraceuticals Inducible in Microalgae.2 型糖尿病和脂肪组织功能障碍对乳腺癌的影响,以及微藻中诱导的营养保健品的潜在益处。
Nutrients. 2024 Sep 25;16(19):3243. doi: 10.3390/nu16193243.
6
Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation.肥胖相关性乳腺癌:危险因素分析与临床评估现状。
Adv Exp Med Biol. 2024;1460:767-819. doi: 10.1007/978-3-031-63657-8_26.
7
Fat Biology in Triple-Negative Breast Cancer: Immune Regulation, Fibrosis, and Senescence.三阴性乳腺癌中的脂肪生物学:免疫调节、纤维化与衰老
J Obes Metab Syndr. 2023 Dec 30;32(4):312-321. doi: 10.7570/jomes23044. Epub 2023 Nov 28.
8
High extracellular glucose promotes cell motility by modulating cell deformability and contractility via the cAMP-RhoA-ROCK axis in human breast cancer cells.高细胞外葡萄糖通过 cAMP-RhoA-ROCK 轴调节细胞的可变形性和收缩性促进人乳腺癌细胞的迁移。
Mol Biol Cell. 2023 Jul 1;34(8):ar79. doi: 10.1091/mbc.E22-12-0560. Epub 2023 May 17.
9
Oxidative Stress and MicroRNAs in Endothelial Cells under Metabolic Disorders.氧化应激与代谢紊乱下内皮细胞中的 microRNAs
Cells. 2023 May 8;12(9):1341. doi: 10.3390/cells12091341.
10
Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies.肥胖与脂肪组织中的免疫代谢变化有关,这些变化可能导致乳腺癌治疗耐药:免疫代谢重编程与新型治疗策略
Cancers (Basel). 2023 Apr 24;15(9):2440. doi: 10.3390/cancers15092440.
罗格列酮通过减少脂肪细胞游离脂肪酸的释放来改善骨骼肌胰岛素抵抗。
Biochem Biophys Res Commun. 2020 Dec 17;533(4):1122-1128. doi: 10.1016/j.bbrc.2020.09.144. Epub 2020 Oct 6.
4
Insulin resistance contributes to racial disparities in breast cancer prognosis in US women.胰岛素抵抗导致美国女性乳腺癌预后的种族差异。
Breast Cancer Res. 2020 May 12;22(1):40. doi: 10.1186/s13058-020-01281-y.
5
Photobiomodulation therapy decreases free fatty acid generation and release in adipocytes to ameliorate insulin resistance in type 2 diabetes.光生物调节疗法可减少脂肪细胞中游离脂肪酸的生成和释放,改善 2 型糖尿病的胰岛素抵抗。
Cell Signal. 2020 Mar;67:109491. doi: 10.1016/j.cellsig.2019.109491. Epub 2019 Dec 4.
6
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.三阴性乳腺癌化疗耐药的机制——我们如何应对挑战。
Cells. 2019 Aug 22;8(9):957. doi: 10.3390/cells8090957.
7
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study.肥胖作为乳腺癌亚型的风险因素:一项前瞻性队列研究的结果。
BMC Cancer. 2018 May 31;18(1):616. doi: 10.1186/s12885-018-4548-6.
8
Triple-negative breast cancers - a panoply of cancer types.三阴性乳腺癌——一系列癌症类型。
Nat Rev Clin Oncol. 2018 Jun;15(6):347-348. doi: 10.1038/s41571-018-0001-7.
9
Adipocytokines and breast cancer.脂肪细胞因子与乳腺癌
Curr Probl Cancer. 2018 Mar-Apr;42(2):208-214. doi: 10.1016/j.currproblcancer.2018.01.004. Epub 2018 Jan 8.
10
Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics.针对乳腺癌治疗中的胰岛素样生长因子-1 系统。
Cancer Treat Rev. 2018 Feb;63:79-95. doi: 10.1016/j.ctrv.2017.11.010. Epub 2017 Dec 6.